Ensign Peak Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,681
Closed -$419K 1807
2022
Q4
$419K Sell
3,681
-103,758
-97% -$11.8M ﹤0.01% 1656
2022
Q3
$6.65M Sell
107,439
-25,563
-19% -$1.58M 0.02% 462
2022
Q2
$10.6M Buy
133,002
+45,038
+51% +$3.59M 0.03% 375
2022
Q1
$9.26M Sell
87,964
-18,649
-17% -$1.96M 0.02% 437
2021
Q4
$11.5M Buy
106,613
+74,407
+231% +$8.02M 0.02% 433
2021
Q3
$3.53M Buy
32,206
+24,997
+347% +$2.74M 0.01% 803
2021
Q2
$675K Hold
7,209
﹤0.01% 1540
2021
Q1
$664K Sell
7,209
-120,358
-94% -$11.1M ﹤0.01% 1543
2020
Q4
$9.33M Sell
127,567
-7,359
-5% -$538K 0.02% 431
2020
Q3
$10.5M Sell
134,926
-10,558
-7% -$820K 0.03% 437
2020
Q2
$8.09M Sell
145,484
-29,140
-17% -$1.62M 0.02% 474
2020
Q1
$5.17M Buy
174,624
+60,264
+53% +$1.78M 0.02% 503
2019
Q4
$4.14M Buy
+114,360
New +$4.14M 0.01% 704